Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Avishkar Diagnostics’ latest CME highlights the potential of Regenerative Medicine and Cosmetic Gynaecology
    Business

    Avishkar Diagnostics’ latest CME highlights the potential of Regenerative Medicine and Cosmetic Gynaecology

    By April 12, 2022No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Read Time:2 Minute, 1 Second

    Dr Prabhu Mishra, President of the International Association of stemcell & Regenerative Medicine (IASRM)

    New Delhi (India), April 12: City Mayor Mrs. Anandita Mukherjee recently inaugurated a CME for doctors and researchers in the field of medical science. The CME that was focused on the recent advancement in healthcare also focused on the impact of advancements on women’s health, social welfare, and education. More than 150 doctors from various specialties attended the CME.

    The CME talked in detail about Regenerative Medicine, stem cells, Platelet Rich Plasma Therapy, Laser, Radio-frequency in aesthetics, and functional medicine. Dr. Shashi Bhushan Pandey, a renowned Radiologist, and Foetal medicine expert who is also the founder-director of Avishkar Diagnostics announced the Centre of Excellence for Cosmetic / Functional Gynaecology, Urogynaecology, and regenerative medicine. This will address many degenerative and chronic conditions like Stress urinary Incontinence, Pelvic floor management, Premature Ovarian failure, and other health complications.

    The CME was a great insight into the future of healthcare after two years of the pandemic. Prabhu Mishra, President of the International Association of stemcell & Regenerative Medicine (IASRM)  was one of the keynote speakers. He talked about the recent developments in the space ofregenerative medicine. He also spoke about cosmetic gynecology and how it can address the intimate health and cosmetic expectations of patients. He expressed his interest to collaborate with scientists, doctors, and academicians to research and achieve newer milestones to improve health and quality of life.

    Cosmetic Gynecology or Female Cosmetic Genital Surgery (FCGS) is one of the fastest-growing subspecialties for women in the elective surgery arena. It needs expert knowledge in Gynecology, Urogynecology, Urology, and Plastic surgery. It involves cosmetic procedures to improve the aesthetic looks of the vaginal region or vulva along with functional vaginal repairing for enhancing or restoring some of the sexual functions that show changes in the wake of childbirth or aging. It also addresses Vaginal atrophy, hormones management, Menopause, Vaginal Rejuvenation, and sexual dysfunctions.

    People generally don’t give importance to the changes that arise in terms of female sexual health post-delivery or as a result of aging. Dr.Shashi expressed the need of giving high importance to female and male sexual health. He said that there should be no stigma around anti-aging and cosmetic care.

    Healthcare professionals are hoping that his CME will open avenues for better communication about taboo topics in healthcare and serve as a knowledge starter.

    About Post Author


    RNT Reporter


    dhaval.rntoday@gmail.com

    https://republicnewstoday.com

    The post Avishkar Diagnostics’ latest CME highlights the potential of Regenerative Medicine and Cosmetic Gynaecology appeared first on Republic News Today.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Duroply Showcases its Built-to-Last Legacy

    November 14, 2026

    Austere Systems Announces H1 FY27 Results

    November 14, 2026

    ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27

    November 14, 2026

    Comments are closed.

    Recent Post
    • Duroply Showcases its Built-to-Last Legacy
    • Austere Systems Announces H1 FY27 Results
    • ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27
    • PAN HR Solution Limited Reports H1 FY27 Results
    • Why Colonialism Still Matters: Museum of British Colonialism to Host Online Panel Discussion on 19 November
    • Dr. R. K. Thukral and the Work of Bringing Neuropsychiatry Closer to Patients
    • From Global Recognition to Academic Excellence: LBSIM’s Continuing Journey After AACSB Accreditation
    • DEV Information Technology Reports Q2 FY27 Total Income of Rs. 63.07 Cr, Up 28 Percent YoY; H1 FY27 Total Income Reaches Rs. 107.72 Cr, Up 16 Percent YoY

    Type above and press Enter to search. Press Esc to cancel.